These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37542280)

  • 1. Association of insulin use with LV remodeling and clinical outcomes in diabetic patients with heart failure and reduced ejection fraction: assessed by cardiac MRI.
    Shi K; Zhang G; Fu H; Huang S; Xu HY; Gao Y; Shi R; Yan WF; Qian WL; Li Y; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2023 Aug; 22(1):201. PubMed ID: 37542280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of diabetes mellitus on left ventricular function and remodeling in hypertensive patients with heart failure with reduced ejection fraction: assessment with 3.0 T MRI feature tracking.
    Zhang G; Shi K; Yan WF; Li XM; Li Y; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2022 May; 21(1):69. PubMed ID: 35524215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic control and clinical outcomes in diabetic patients with heart failure and reduced ejection fraction: insight from ventricular remodeling using cardiac MRI.
    Shi K; Zhang G; Fu H; Li XM; Gao Y; Shi R; Xu HY; Li Y; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2024 Apr; 23(1):148. PubMed ID: 38685007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in clinical profile, left ventricular remodeling and cardiovascular outcomes among diabetic patients with heart failure and reduced ejection fraction: a cardiac-MRI-based study.
    Shi K; Zhang G; Fu H; Li XM; Jiang L; Gao Y; Qian WL; Shen LT; Xu HY; Li Y; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2024 Jul; 23(1):266. PubMed ID: 39039567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced thoracic skeletal muscle size is associated with adverse outcomes in diabetes patients with heart failure and reduced ejection fraction: quantitative analysis of sarcopenia by using cardiac MRI.
    Shi K; Zhang G; Fu H; Li XM; Yu SQ; Shi R; Yan WF; Qian WL; Xu HY; Li Y; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2024 Jan; 23(1):28. PubMed ID: 38218882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of type 2 diabetes mellitus on left ventricular deformation in non-ischemic dilated cardiomyopathy patients assessed by cardiac magnetic resonance imaging.
    Shen MT; Li Y; Guo YK; Jiang L; Gao Y; Shi R; Yang ZG
    Cardiovasc Diabetol; 2022 Jun; 21(1):94. PubMed ID: 35659302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF).
    Lee MMY; Brooksbank KJM; Wetherall K; Mangion K; Roditi G; Campbell RT; Berry C; Chong V; Coyle L; Docherty KF; Dreisbach JG; Labinjoh C; Lang NN; Lennie V; McConnachie A; Murphy CL; Petrie CJ; Petrie JR; Speirits IA; Sourbron S; Welsh P; Woodward R; Radjenovic A; Mark PB; McMurray JJV; Jhund PS; Petrie MC; Sattar N
    Circulation; 2021 Feb; 143(6):516-525. PubMed ID: 33186500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of diabetes mellitus on the development of left ventricular contractile dysfunction in women with heart failure and preserved ejection fraction.
    Shi K; Yang MX; Huang S; Yan WF; Qian WL; Li Y; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2021 Sep; 20(1):185. PubMed ID: 34521391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The additive effects of type 2 diabetes mellitus on left ventricular deformation and myocardial perfusion in essential hypertension: a 3.0 T cardiac magnetic resonance study.
    Li XM; Jiang L; Guo YK; Ren Y; Han PL; Peng LQ; Shi R; Yan WF; Yang ZG
    Cardiovasc Diabetol; 2020 Sep; 19(1):161. PubMed ID: 32998742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The additive effects of kidney dysfunction on left ventricular function and strain in type 2 diabetes mellitus patients verified by cardiac magnetic resonance imaging.
    Zhang Y; Wang J; Ren Y; Yan WF; Jiang L; Li Y; Yang ZG
    Cardiovasc Diabetol; 2021 Jan; 20(1):11. PubMed ID: 33413395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis.
    Zhang N; Wang Y; Tse G; Korantzopoulos P; Letsas KP; Zhang Q; Li G; Lip GYH; Liu T
    Eur J Prev Cardiol; 2022 Feb; 28(17):1961-1973. PubMed ID: 34792124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between saxagliptin use and left ventricular diastolic function assessed by cardiac MRI.
    Wong KCK; Ismail HS; Connelly KA; Verma S; Ng MY; Deva DP; Yan AT; Jimenez-Juan L
    Acta Diabetol; 2024 Jan; 61(1):91-97. PubMed ID: 37691025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Santos AB; Roca GQ; Claggett B; Sweitzer NK; Shah SJ; Anand IS; Fang JC; Zile MR; Pitt B; Solomon SD; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002763. PubMed ID: 27056882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of Left Ventricular Strain by Cardiac Magnetic Resonance Feature-Tracking to Predict Cardiovascular Events in Patients With and Without Heart Failure.
    Sardana M; Konda P; Hashmath Z; Oldland G; Gaddam S; Miller R; Satija V; Ansari B; Lee J; Mustafa A; Akers SR; Chirinos JA
    Am J Cardiol; 2019 Apr; 123(8):1301-1308. PubMed ID: 30717885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adverse impact of coronary artery disease on left ventricle systolic and diastolic function in patients with type 2 diabetes mellitus: a 3.0T CMR study.
    Wang J; Li Y; Guo YK; Huang S; Shi R; Yan WF; Qian WL; He GX; Yang ZG
    Cardiovasc Diabetol; 2022 Feb; 21(1):30. PubMed ID: 35193565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive effect of dapagliflozin on left ventricular longitudinal function for type 2 diabetic mellitus patients with chronic heart failure.
    Tanaka H; Soga F; Tatsumi K; Mochizuki Y; Sano H; Toki H; Matsumoto K; Shite J; Takaoka H; Doi T; Hirata KI
    Cardiovasc Diabetol; 2020 Jan; 19(1):6. PubMed ID: 31910853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of type 2 diabetes mellitus on left ventricular diastolic function in patients with essential hypertension: evaluation by volume-time curve of cardiac magnetic resonance.
    Yan WF; Gao Y; Zhang Y; Guo YK; Wang J; Jiang L; Li Y; Yang ZG
    Cardiovasc Diabetol; 2021 Mar; 20(1):73. PubMed ID: 33766020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle metaboreflex control of left ventricular systolic function in heart failure with reduced ejection fraction.
    Boyes NG; Nelson MD; Palmero Canton A; Luchkanych AMS; Khan MR; Bare I; Haddad T; Abdalla S; Marshall RA; Morse CJ; Zhai A; Haddad H; Marciniuk DD; Karjala G; Olver TD; Tomczak CR
    J Appl Physiol (1985); 2023 Aug; 135(2):279-291. PubMed ID: 37348013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction.
    Lin SN; Phang KK; Toh SH; Chee KH; Zaman Huri H
    Front Endocrinol (Lausanne); 2020; 11():448. PubMed ID: 32754118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.